Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorLOPEZ SOTO, ALFONSO
dc.contributor.authorFernández-Moyano, Antonio
dc.contributor.authorBarbé Gil-Ortega, José
dc.contributor.authorSan-José, Antonio
dc.contributor.authorAgustí, Antònia
dc.contributor.authorVidal, Xavier
dc.contributor.authorFormiga, Francesc
dc.date.accessioned2025-01-27T11:26:05Z
dc.date.available2025-01-27T11:26:05Z
dc.date.issued2014-10
dc.identifier.citationSan-José A, Agustí A, Vidal X, Formiga F, López-Soto A, Fernández-Moyano A, et al. Inappropriate prescribing to older patients admitted to hospital: A comparison of different tools of misprescribing and underprescribing. Eur J Intern Med. 2014 Oct;25(8):710–6.
dc.identifier.issn1879-0828
dc.identifier.urihttps://hdl.handle.net/11351/12495
dc.descriptionInappropriate prescribing; Older multimorbidity patients; Potentially prescribing omissions
dc.description.abstractPurpose This study aims to assess inappropriate prescribing (IP) to elderly patients during the month prior to hospitalization and to compare different IP criteria. Methods An observational, prospective and multicentric study was carried out in the internal medicine services of seven Spanish hospitals. Patients aged 75 years and older were randomly selected after hospital admission for a year. To assess potentially inappropriate medicines (PIMs), the Beers and STOPP criteria were used and to assess potentially prescribing omissions (PPOs), the START criteria and ACOVE-3 medicine quality indicators were used. An analysis to assess factors associated with IP was performed. Results 672 patients [median age (Q1–Q3) 82 (79–86) years, 55.9% female] were included. Median prescribed medicines in the month prior to hospitalization were 10(Q1–Q3 7–13). The prevalence of IP was 87.6%, and 54.3% of patients had PIMs and PPOs concurrently. A higher prevalence rate of PIMs was predicted using the STOPP criteria than with the Beers criteria (p < 0.001) and a higher prevalence of PPOs using the ACOVE-3 criteria than using the START criteria (p < 0.001) was observed. Polypharmacy (≥ 10 medicines) was the strongest predictor of IP [OR = 11.34 95% confidence interval (CI) 4.96–25.94], PIMs [OR = 14.16, 95% CI 6.44–31.12], Beers-listed PIMs [OR = 8.19, 95% CI 3.01–22.28] and STOPP-listed PIMs [OR = 8.21, 95% CI 3.47–19.44]. PIMs was the strongest predictor of PPOs [OR = 2.79, 95% CI 1.81–4.28]. Conclusions A high prevalence of polypharmacy and PIMs and PPOs were reported. More than half the patients had simultaneous PIMs and PPOs. The related factors to PIMs and PPOs were different.
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesEuropean Journal of Internal Medicine;25(8)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectHospitals - Ingressos i altes
dc.subjectPersones grans
dc.subjectErrors de medicació
dc.subject.meshInappropriate Prescribing
dc.subject.meshMedication Errors
dc.subject.meshAged
dc.subject.meshPolypharmacy
dc.subject.meshHospitalization
dc.titleInappropriate prescribing to older patients admitted to hospital: A comparison of different tools of misprescribing and underprescribing
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.ejim.2014.07.011
dc.subject.decsprescripción inadecuada
dc.subject.decserrores de medicación
dc.subject.decsanciano
dc.subject.decspolimedicación
dc.subject.decshospitalización
dc.relation.publishversionhttps://doi.org/10.1016/j.ejim.2014.07.011
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[San-José A, Barbé J] Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Multimorbidity and Elderly Patients Group of the Spanish Society of Internal Medicine, Spain. [Agustí A, Vidal X] Servei de Farmacologia Clínica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Fundació Institut Català de Farmacologia, Barcelona, Spain. Departament de Farmacologia, Terapèutica i Toxicologia, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Formiga F] Internal Medicine Service, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain. Multimorbidity and Elderly Patients Group of the Spanish Society of Internal Medicine, Spain. [López-Soto A] Internal Medicine Service, Hospital Clínic, Barcelona, Spain. Multimorbidity and Elderly Patients Group of the Spanish Society of Internal Medicine, Spain. [Fernández-Moyano A] Internal Medicine Service, Hospital San Juan De Dios del Aljarafe, Sevilla, Spain. Multimorbidity and Elderly Patients Group of the Spanish Society of Internal Medicine, Spain
dc.identifier.pmid25179678
dc.identifier.wos000343807000012
dc.rights.accessrightsinfo:eu-repo/semantics/restrictedAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record